Ticker Details
Amphastar Pharmaceuticals, Inc. Amphastar Pharmaceuticals Inc is a specialty pharmaceutical company engaged in developing, manufacturing, marketing and selling generic and proprietary injectable & inhalation products. Its products are used in hospitals or urgent care clinical settings.
IPO Date:	June 25, 2014
Sector:	Healthcare
Industry:	Drug Manufacturers
Market Cap:	$918.82M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.47 | 1.90%
Avg Daily Range (30 D):	$0.33 | 1.65%
Avg Daily Range (90 D):	$0.47 | 2.32%

Institutional Daily Volume
Avg Daily Volume:	.26M
Avg Daily Volume (30 D):	.33M
Avg Daily Volume (90 D):	.43M

Trade Size
Avg Trade Size (Sh.):	62
Avg Trade Size (Sh.) (30 D):	45
Avg Trade Size (Sh.) (90 D):	49

Institutional Trades
Total Institutional Trades:	2,674
Avg Institutional Trade:	$1.78M
Avg Institutional Trade (30 D):	$1.62M
Avg Institutional Trade (90 D):	$1.77M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.04M
Avg Closing Trade (30 D):	$1.49M
Avg Closing Trade (90 D):	$1.86M
Avg Closing Volume:	70.63K

News

Oct 9, 2025 @ 1:31 PM Teva, Viatris On Investor Watch As White House Spa... Source: Vandana Singh

Jun 5, 2025 @ 5:00 PM Global Antidote Market to Cross the USD 4 Billion ... Source: Delveinsight

Sep 6, 2024 @ 5:46 PM JP Morgan Shows Most Interest In Teva, Organon As ... Source: Vandana Singh

Jul 23, 2024 @ 5:01 PM HCA Healthcare (HCA) Beats on Q2 Earnings, Ups 202... Source: N/A

May 30, 2024 @ 6:06 AM Amphastar Pharmaceuticals: Buy When Fear Is Overbl... Source: James Long

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$1.74	$.69	$.14
Diluted EPS	$1.69	$.67	$.14
Revenue	$730.02M	$183.9M	$171.17M
Gross Profit	$348.11M	$93.47M	$70.32M
Net Income / Loss	$78.55M	$30.35M	$6.42M
Operating Income / Loss	$114.29M	$39.73M	$13.63M
Cost of Revenue	$381.91M	$90.43M	$100.85M
Net Cash Flow	$35.93M	$52.68M	$.76M
PE Ratio